companies need to consider their eDetailing options carefully to choose a model
that will be right for their particular product, target physician group and
country being mindful of the European regulatory differences to their
US counterparts. Many pharmaceutical companies are simply starting a pilot with
one or two models and a key European market but this will not necessarily be
sufficient to reach a conclusion for all cases if these specific areas have
not been analysed sufficiently. This workshop focuses on untangling the key
issues for success in eDetailing (including key sales reps if possible to get
their buy-in and expertise in forming a strategy):
- Which products
are best for eDetailing (depending on the product spot in its lifecycle)?
- Which type of
physicians should be chosen to participate for highest ROI?
- What type of
eDetailing to use?
- How to stay
within the European regulatory codes while still incentivising physicians
- What are the
most effective approaches and models in Europe in terms of what kinds of eDetailing
work best to achieve ROI?
- How to move
forward with pilots?
- How to evaluate
pilots and plan roll-out?
- What metrics
to be used to measure ROI?
- How these metrics
are used to calculate ROI and who calculates the ROI?
quote: Good content and activites provided a blueprint for me to now analyse
our current eDetailing plans more rigorously and build in stronger ROI measures
Delegate from an inter-company Masterclass on eDetailing (attended by
8 pharmaceutical companies)